Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

iPS cell modeling of cardiometabolic diseases.

Journal of cardiovascular translational research - 1 Feb 2013

Nakamura Kenta, Hirano Ken-ichi, Wu Sean M

Abstract excerpt

Cardiometabolic diseases encompass simple monogenic enzyme deficiencies with well-established pathogenesis and clinical outcomes to complex polygenic diseases such as the cardiometabolic syndrome. The limited availability of relevant human cell types such as cardiomyocytes has hampered our ability to adequately model and study pathways or drugs relevant to these diseases in the heart. The recent discovery of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Heart Diseases
Share to AMP-Activated Protein Kinases
Share to Glycogen Storage Disease Type II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ichthyosiform Erythroderma, Congenital

Share to Lipid Metabolism, Inborn Errors

Share to Metabolic Diseases

Share to Muscular Diseases

Share to Myocytes, Cardiac

Source

Open in PubMed Open full text

Identifiers

PMID: 23070616
DOI: 10.1007/s12265-012-9413-4
PMCID: PMC3547131

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

iPS cell modeling of cardiometabolic diseases.PMID 23070616Read ↗

Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and ChallengesSemantic proximity Read ↗

Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery.Semantic proximity Read ↗

Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.Semantic proximity Read ↗

Modelling Diabetic Cardiomyopathy: Using Human Stem Cell-Derived Cardiomyocytes to Complement Animal ModelsSemantic proximity Read ↗

Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.Semantic proximity Read ↗

Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem CellsSemantic proximity Read ↗

Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.Semantic proximity Read ↗

Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging ModelsSemantic proximity Read ↗

Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.Semantic proximity Read ↗

The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.Semantic proximity Read ↗

Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.Semantic proximity Read ↗

Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.